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Abstract: During the past two decades, with a huge and rapidly
increasing clinical need for bone regeneration and repair, bone
substitutes are more and more seen as a potential solution.
Major innovation efforts are being made to develop such sub-
stitutes, some having advanced even to clinical practice. It is
now time to turn to natural biomaterials. Nacre, or mother-of-
pearl, is an organic matrix-calcium carbonate coupled shell
structure produced by molluscs. In vivo and in vitro studies
have revealed that nacre is osteoinductive, osteoconductive,
biocompatible, and biodegradable. With many other outstand-
ing qualities, nacre represents a natural and multi-use
biomaterial as a bone graft substitute. This review aims at
summarising the current needs in orthopaedic clinics and the
challenges for the development of bone substitutes; most of
all, we systematically review the physiological characteristics
and biological evidence of nacre’s effects centred on osteogen-
esis, and finally we put forward the potential use of nacre as a
bone graft substitute. VC 2016 Wiley Periodicals, Inc. J Biomed Mater
Res Part A: 00A:000–000, 2016.
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INTRODUCTION
Nacre, or mother-of-pearl, is a calcium carbonate structure
present in mollusc shells. In vivo and in vitro studies have
revealed that nacre is osteoinductive, osteoconductive, biocom-
patible and biodegradable. Its vast and extensive availability,
competitive cost, opacity to X rays, unique hierarchal structure,
chemical complexity and outstanding mechanical properties all
make nacre a natural and multi-use biomaterial as a bone graft
substitute. Nevertheless, nacre has not yet drawn enough atten-
tion from investigators. This review aims at pointing out the
current needs in orthopaedic clinics and the challenges for the
development of bone substitutes, and principally to systemati-
cally review the physiological characteristics and biological evi-
dence of nacre’s contribution centred on osteogenesis, and thus
to foresee the potential use of nacre as a bone graft substitute.
What are the real needs for a bone graft substitute in
current orthopaedic clinics?
There are three main types of bone grafts: autografts, allo-
grafts, and bone graft substitutes. There are, however, some
well-known drawbacks, for example, restricted supply or
disease transmission. The application of autograft and allo-
graft is greatly limited.1,2 Thus, hope has turned to bone
graft substitutes.3 To date, no one bone graft substitute is
able to satisfy all the clinical demands. Large bone loss due
to trauma, infection and tumoral diseases at different sites
should be treated differently. To meet the major require-
ments of a bone graft substitute, a 4Fs rule was introduced:
form, function, fixation and formation.3 Form means that the
scaffold should fill the bone defect cavities. Function is the
load-bearing property. Fixation requires scaffolds to be
securely attached to the bone at the defect margins, elimi-
nating motion between host bone and scaffold to avoid non-
union and pseudarthrosis. Formation means that scaffolds
should promote bone formation. For all cases, the 4Fs
should be respected. While cranial surgery has more
demands concerning the form, orthopaedic surgery, particu-
larly the treatment of severe fracture or limb reconstruction,
has a higher requirement for function and fixation. In the
case of delayed healing fractures, non-unions and infection,
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orthopaedic clinics need treatment for bone formation. Fur-
thermore, in spinal surgery, implants in the vertebral body
need to be injectable, particularly when a mini-invasive
approach is taken. The handling characteristics of different
substitutes are very important for the orthopaedic surgeon.
Similarly, the implants for maxillofacial and dental surgery
have different requirements. Clinically, the choice of bone
graft substitutes depends on several factors4: (1) the
intended clinical application; (2) defect size and total bone
mass required; (3) biomechanical properties; (4) chemical
composition; (5) availability; (6) desired bioactivity (osteo-
conductivity/osteoinductivity/osteogenicity); (7) desired
resorption rate; (8) handling characteristics; (9) associated
side effects; (10) cost; (11) ethical issues. On the whole, the
bone graft substitute should meet the multiple needs of any
given specific case.
Current mainstream ideas on bone graft substitutes and
the main dilemma
The focus on synthetic bone graft substitutes is currently
aimed at improving their osteogenic, osteoconductive and
osteoinductive potential. Osteogenesis implies the formation
of bone matrix by bone-forming cells. Osteoconduction
means bone growth on a surface: an osteoconductive sur-
face permits bone growth on its surface or deeper down
into pores, channels or pipes.5 Osteoinduction means the
recruitment of undifferentiated mesenchymal stem cells
from the surrounding tissue and the stimulation of these
cells to develop into preosteoblasts for bone regeneration.5,6
Osseointegration is also an important concept, that of the
stable anchorage of an implant achieved by direct bone-to-
implant contact.5 Although >21,000 papers on bone substi-
tutes have been published in the last 20 years (PubMed
search), bone substitutes have not all led to clinical practice
because of several limitations or challenges,3,4,7–9 related to
techniques, business, or philosophy. The most urgent or
toughest-to-satisfy ones are the following: (1) to develop
mechanically strong porous scaffolds that retain proper vas-
cularization and host integration properties; (2) to assess
graft functionality in load-bearing large animal models; (3)
to avoid single-component strategies involving cells, factors,
or defect-filling materials; (4) to modulate the host’s
foreign-body response; (5) to solve the contradiction
between the strategies incorporating all the necessary com-
ponents with the difficulty in obtaining regulatory approval;
(6) to assess technical difficulties, efficiency, cost during the
manufacturing process and safety risks during the pre-
implantation period; (7) to meet specific market needs.
NACRE
The core biological knowledge on nacre
Nacre (mother-of-pearl) is an acellular calcium carbonate
composite produced worldwide by bivalves, gastropods, and
cephalopods as an internal shell coating [Fig. 1(A)]. The
structure and formation of nacre, particularly in giant oys-
ters Pinctada (P.) maxima and P. magaritifera, is among the
best-studied examples of calcium carbonate biomineraliza-
tion, which gives a biomimetic approach for current bone
substitutes.
Physical structure. P. margaritifera and P. maxima are
among the largest Pinctada species (family Pteriidae). The
largest P. margaritifera shells can reach 30 cm in diameter,
versus 20–25 cm for P. maxima. The thickness of the P.
maxima nacre layer can be up to 2 cm.10 These parameters
endow nacre with great potential to design bone graft sub-
stitutes. At the microscopic scale, nacre is composed of
aragonite crystal tablets covered by and embedded in an
organic matrix. The typical structure of Pinctada nacre
involves a regular brick wall-like edifice, composed of
pseudohexagonal aragonite tablets about 0.5-mm in thick-
ness -thick and 5–15 mm in diameter [Fig. 1(B)].11 The tab-
lets are arranged in continuous parallel laminae separated
by sheets of an interlamellar organic matrix.12 On the
nano-scale, the tablet itself is a composite containing both
the mineral structure of aragonite and the intracrystalline
organic material [Fig. 1(C)].12,13 Because of the particular
layered microstructure and organic components, nacre
presents excellent compressive stress properties better
than those of bone. The Young’s modulus, or the elastic
modulus, is 30–40 GPa for nacre versus 20 GPa for bone,
and the respective values of resistance to failure are 185–
200 MPa versus 140 MPa.14,15
FIGURE 1. Structure of the nacreous layer of Pinctada: A: Lustrous nacreous layer as an internal shell coating; B: Scanning Electron Microscopy
picture showing the characteristic brick and mortar structure of nacre; C: Atomic Force Microscopy image in Phase Contrast mode (1 3 1 mm2)
at the nanometer (nm) length scale.
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Chemical composition. The inorganic fraction (97%) of nacre
is composed of calcium carbonate in the form of aragonite. The
organic fraction (3%) is a mixture of proteins, peptides, glyco-
proteins, chitin, lipids, and pigments.16 To date, >50 proteins
and 50 peptides from nacre have been identified (UniProt pro-
tein database, see www.uniprot.org). The organic molecules
can be extracted with aqueous and organic solvents.17
NACRE AND BONE
The formation of bone and shell are both multi-gene regu-
lated and environmentally-related biomineralization pro-
cesses. Nacre is an acellular structure of the external
skeleton of molluscs whereas bone is a cellularized struc-
ture of the internal skeleton of vertebrates. These two
highly organized structures share an intervening organic
matrix deposited by specialized cells: bone cells in verte-
brates and epithelial mantle cells in molluscs. The organic
framework provides a scaffold for crystallization and directs
the mineralization. A good understanding and comparison
of their physiological formation and hierarchical structure is
a necessary prerequisite to promote the value of nacre as a
bone graft substitute.
Biology of bone. Bone can be seen as an open cell compos-
ite material composed of osteogenic cells, an extracellular
matrix, proteins, growth factors, mineral calcium phosphate
in the form of hydroxyapatite and a complex vascular sys-
tem. Ossification occurs via intramembraneous or endochon-
dral pathways. In both cases, mesenchymal cellular
condensation first occurs and serves as a template for sub-
sequent ossification. The mesenchymal stem cells (MSCs)
are stimulated or regulated by abundant signal molecules,18
so that they migrate to a specific site, proliferating and dif-
ferentiating into osteoblasts. Osteoblast differentiation
occurs in three stages: (1) cell proliferation, (2) matrix mat-
uration, and, (3) mineralization. Both ossification processes
are involved during bone remodelling to maintain a balance
between osteoclastic bone resorption and osteoblastic bone
formation, in order to always maintain healthy bone, and
homeostasis between the calcium and phosphates.
Structure of bone. There are two main structures, the outer
cortical bone and the inner cancellous trabecular bone. Cort-
ical bone is very dense and consists of hierarchical struc-
tures. They range from the solid material (>3 mm), to the
cylindrically organized osteons (10–500 lm), lamellae (3–
20 lm), and the collagen-mineral composite (60–600 nm).
The primary function of cortical bone is to allow torsion,
and to furnish bending resistance and compressive strength.
Cancellous bone consists of an interconnected network of
trabeculae which is usually filled with marrow.19 The
porous trabeculae are metabolically active and are remod-
elled more frequently than cortical bone.
Conservation of signal molecules involved in biomineralization
control in vertebrate bone and mollusc shell. It is believed
that there is conservation of the signal molecules involved
in the biomineralization control in calcifying matrices of
bone and shell. One facet of matrix-mediated control arises
from the bone and nacre interaction. In vivo experiments of
nacre implants have established its biocompatibility and
osteogenic activity in bone (detailed in part 3.1). In vitro
studies have provided evidence of the presence, in the nacre
organic matrix, of signal molecules responsible for the
recruitment of mammal cells in the osteogenic pathway and
bone cell activation undergoing a complete sequence of min-
eralization (detailed in In vitro Studies section).
THE SYSTEMIC BIOLOGICAL EVIDENCE OF NACRE FOR
BONE GRAFT SUBSTITUTION
The medical use of nacre in humans has a long history. As
recorded in Bencao Tujing (Illustrated Classics of Materia
Medica) written in 1061, traditional Chinese medicine used
a decoction of nacre powder to treat hepatopathy for
>1000 years. Discovered in 1931, teeth made of nacre in
Mayan skulls integrated perfectly into the surrounding bone
[Fig. 2(A)].20 The suggested use of nacre as a bone graft
substitute was a major breakthrough made in 1992, when
Lopez et al.26 discovered that the nacre from P. maxima was
simultaneously biocompatible and osteoinductive. Ever
since, attention has been paid continuously to nacre. In
what follows, results of the major in vivo and in vitro stud-
ies will be introduced.
In vivo studies. Inspired by the nacre teeth found in Mayan
skulls, nacre, as a bone graft substitute, was first designed
many centuries later to restore dental defects in dogs and
humans.21,27 For the last 20 years, nacre has been designed
more ingeniously and tested, in vivo, at various implantation
sites for different uses (Table I and Fig. 2). New bone for-
mation stimulated by nacre has been observed in humans,
rats, sheep, rabbits and pigs. The implantation site involved
the maxillary, mandible [Fig. 2(B)], midshaft of femur or
femoral epiphysis, first metatarsus, in lumbar vertebrae or
between the transverse processes. More recently, nacre has
been designed as an injectable powder [Fig. 2(C)], or in the
shape of rods [Fig. 2(D)], trochlea [Fig. 2(E)], screws [Fig.
2(F)] and plates, to match the clinical needs for orthopaedic
bone devices.
Biocompatibility, osteoinduction, osteoconduction, and
osseointegration of nacre. In 1997, Atlan et al.28 mixed
fine nacre powder into a slurry with the blood of eight
patients suffering from bone loss in their upper jaw. The
slurry was injected into tissues where the bone was miss-
ing. After 6 months, biopsies showed that the nacre had
been well accepted by the local tissues. The newly formed
bone was tightly welded to the nacre particles without any
intervention of soft or fibrous tissue [Fig. 3(A)]. Osteoblasts
had been activated and new healthy bone had formed
throughout the implant [Fig. 3(B)], while the nacre particles
slowly dissolved away gradually and centripetally, replaced
by immature woven bone and then mature lamellar bone
[Fig. 3(C)]. Thus, the qualities of biocompatibility, osteoin-
duction, osteoconduction, and osseointegration of nacre
were all proven in a human, which was further confirmed
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by all the subsequent in vivo studies when nacre was
implanted in a bone environment (Fig. 4).
Comparison between nacre and autologous bone
graft. Lamghari et al.32 implanted nacre in rabbits to evalu-
ate the possibility of arthrodesis of lumbar spine transverse
processes for 11 weeks. The nacre was compared to autolo-
gous bone grafts from the iliac crest of each rabbit. Results
showed that nacre was well tolerated by the host tissue,
stimulated a continuing endochondral bone formation, and
formed a solid fusion between the transverse processes in
one-third of the rabbits by week 5 and two-thirds after 11
weeks. After that period, a solid fusion was formed in all
rabbits implanted with autologous bone graft, and no bone
formation in sham operated rabbits. Thus, nacre induced
spinal fusion in an acceptable percentage of the cases.
Comparison between nacre and hydroxyapatite coated
titania (THA). The comparison between raw nacre and THA
was made after 14 days of implantation in the midshafts of
rat femurs.29 By in situ hybridization using RNA probes
complementary to collagen I RNA, osteonectin RNA and
osteocalcin RNA, nacre cylinders stimulated a faster osteo-
genesis, which progressed beyond the phase of maximal
synthetic activity, and a better osseointegration was
observed than with THA.
Comparison between nacre and b-tricalcium phosphate
(b-TCP). Rod-shaped nacre or b-TCP were implanted in the
mandible of 8 male guinea pigs by bilateral drilling proce-
dures, while 2 pigs were sham-operated.34 The results
showed that nacre induced the highest amount of new bone
formation, followed by the b-TCP and the sham-operated
group, respectively.
Comparison between nacre and polymethylmethacrylate
(PMMA). Lamghari et al.22,25,31 compared nacre powder and
PMMA in sheep vertebrae. Experimental cavities were pre-
pared in the lumbar vertebrae of sheep, and then filled with
injectable nacre powder [Figs. 2(C) and 4(D)], PMMA or left
empty. The vertebrae sections were performed 1, 8, 12
weeks after surgery, and evaluated histologically and mor-
phometrically. The empty cavities were filled by fatty diffuse
tissue [Fig. 4(C)]. No new bone was formed in the empty
cavities [Fig. 4(E)], nor in those filled with PMMA. However,
layers of newly formed bone, both woven and lamellar, in
different stages of maturation in contact with or adjacent to
the dissolving nacre powder were observed [Fig. 4(F)], con-
firming the results of an earlier study.28
Biodegradability of nacre. To understand the mechanisms
of biodegradation is an important issue in the choice of
materials and implant design.30 The shape of nacre implants
and endosseous sites are two important factors.
FIGURE 2. Different designs of nacre as Bone graft substitutes. A: Nacre incisor in the jaw of an Ancient Mayan individual. Excellent bone fusion
was shown by X-ray imaging;20 B: bioracine of nacre at levels of 12, 22, 15, and 25 in human maxillary, 4 months after implantation;21 C: Inject-
able powder of nacre ($), implanted in sheep vertebrae, 1 week after implantation;22 D: Nacre (N) in cylinder shape implanted in sheep femoral
epiphysis, 10 months after implantation;23 E: Nacre in trochlea shape as substitute of sheep femoral trochlea;24 F: Nacre (N) in screw shape
implanted in sheep first metatarsus, 2 months after implantation.25
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When raw pieces of nacre were implanted in dogs’,27 or
humans’ dental defects,21 or sheep femur epiphysis23 for as
long as 10 months, nacre appeared sustained, and no osteo-
clasts or absorption was observed at the bone/nacre inter-
face. On the other hand, nacre powder (particle size 50–150
lm) was gradually dissolved in rabbit vertebrae, beginning
8 weeks after surgery.28 No giant cells or macrophages
were observed.36 The result was confirmed by the study in
a human maxillary,28 over 6 months after implantation, and
16 weeks after implantation in rat femurs.30 It was believed
that a physicochemical dissolution was involved in the bio-
degradation of nacre,30 but, some nacre powder was always
observed at the end of all these studies.
Later, it was revealed that the change rate of the nacre/
bone surface depended on the endosseous implantation site
and the nacre/bone interaction.33 Smooth-surfaced nacre
pieces were implanted in sheep femurs after a midshaft
hemidiaphysis resection of the femur bone to match the
nacre. Bone/nacre and bone-marrow/nacre interfaces were
analyzed at 3, 6, and 9 months after the surgery. The results
showed that, the nacre surfaces facing bone marrow were
always more irregular than when implanted in a
mineralized-bone, and the changes at the nacre interfaces
appeared to be site-dependent rather than time related. The
presence of giant macrophage cells was confirmed in the
first metatarsus of sheep, submitted to a simultaneous
TABLE I. In Vivo Studies on the Osteogenic Activity of Nacre as a Bone Graft Substitute
Reference
Species of Nacre;
Implant Design
Experimental Subject;
Implantation
Site (n5) Follow-up Principal Results
199728 P. maxima; powder,
particle size: 50–100
lm, mixed with auto-
logous venous blood
Human (8), maxillary
alveolar bone
6 months Osteogenesis, biodegradable gradu-
ally and centripetally, replaced
with immature and then mature
lamellar bone
199729 P. margaritifera;
cylinders,
2-mm diameter and
3-mm high
Rat (2), midshaft
femur
14 days Nacre has a higher osteogenic
bioactivity than titania-
hydroxyapatite composite
199923 P. maxima; cylinder,
6-mm mean diameter;
15-mm length
Sheep (6), femoral
epiphysis
3 months (n 5 3),
10 months (n 5 3)
Osteogenesis and biocompatibility
of nacre, continuity between the
nacre and the bone
200030 P. margaritifera;
granules: diameters
<2 mm
Rat (72), back muscle
and femur
1, 2, 4, 8, and 16
weeks
Nacre is biocompatible, biodegrad-
able and osteoconductive materi-
als; Aragonite-bone
bonding via a phosphorous-rich
layer
200131 P. maxima; mixture of
powder (particle size:
50–150 lm) with
autologous venous
blood
Sheep (11), upper
lumbar vertebrae
(L1-L7)
1 week (n 5 3),
2 months (n 5 3),
3 months (n 5 5)
Nacre stimulates bone-forming cells
in vertebrae and results in new
bone formation
200132 P. maxima; mixture of
powder (particle size:
50–150 lm) with auto-
logous venous blood;
graft volume: 2.5 mL
Rabbit (15), lumbar
vertebrae (L5-L6)
2 weeks (n 5 3),
5 weeks (n 5 3),
11 weeks (n 5 3)
Nacre stimulates the formation of a
bone bridge between the trans-
verse processes of rabbit lumbar
vertebrae
200533 P. maxima; nacre pieces,
20 mm length and
13 mm in diameter
Sheep (14), midshaft
femur
3 months (n 5 5),
6 months (n 5 5),
9 months (n 5 4)
Raw nacre implants are sustained
when implanted into bone tissue
in spite of a limited biodegrada-
tion process
201234 P. maxima; rod-shaped,
2 3 2 3 2 mm3
Pig (10), mandible 1 month (n 5 5),
2 months (n 5 5)
Nacre-implanted group exhibits the
highest new bone formation,
without any fibrous tissue, com-
pared to b-tricalcium phosphate
implanted or sham-operated
group
201224 P. maxima; trochlea
shape (22 3 15 3
10 mm3)
Sheep (6), femoral
trochlea
3 months (n 5 3),
6 months (n 5 3)
Biocompatibility, good tolerance in
joint, osteochondroinductivity,
endochondral ossification
201425 P. maxima; screws Sheep (5), first
metatarsus
2 months Erosion of nacre is observed; The
interface shows a toothed-comb
appearance; The interposing
organic layer is not observed
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remodelling process that implied both erosion by giant mac-
rophage cells, and bone apposition on the previously eroded
areas [Fig. 4(A,B)].25 In general, the in vivo biodegradability
of nacre is a highly variable parameter depending on the
size, shape, and endosseous implantation site. Nacre blocks
are sustained during a period of bone regeneration and
bone remodelling though a limited biodegradation, while,
nacre powder dissolves much more quickly than nacre
blocks. It is possible to make nacre absolutely degradable
for a short period if the nacre powder is fine enough.
In vitro studies
In vitro studies, of which the results are shown in Table II,
have been carried out to explain all that has been observed in
FIGURE 3. Osseointegration of nacre in human bone environment. Nacre powder was implanted in defective human maxillary bone; the images
here were taken after 6 months of implantation.28,35 The images above are respectively microradiography (A), histological (B, basic fuchsine
staining) and polarised light images (C). A shows newly-formed bone (NB, low X-ray density) throughout the nacre (N, high X-ray density),
welded together without intervening fibrous tissue, as shown in B. The bone surface was covered by the osteoid borders lined with osteoblasts.
C: The new bone was composed of woven bone (W) and lamellar bone (LB) in close contact with the nacre implants. A 3 26; B and C, 3157.
FIGURE 4. Osseointegration and biodegradation of nacre in sheep. A: Histological aspect of nacre screw after a 2-month implantation period in
the first metatarsus.25 Note the nacre erosion by giant cells; B is a higher magnification of A at the interface, showing bone apposition and ero-
sion of nacre. Toluidine blue staining: Bone (in blue) and nacre (n, unstained); C: Histology of empty cavity (light microscopy) in vertebrae,
showed a bone defect at 12 weeks post-surgery. Cavity (C) was filled by fatty diffuse tissue (*). Body of the vertebrae (white arrow), 340;25 D to
F show bone defects in vertebrae.22 D: Bone cavity was filled with nacre powder (N), 1 week post-surgery; vertebral trabecular bone (?), polar-
ised light image, 325; E: The bone around the cavity (C) without nacre was organised into concentric rings (*), no new bone formation at 12
weeks post-surgery, contact microradiograph, 325; F: New bone formation and bone remodelling were observed in the cavity (C) with nacre at
8 weeks post-surgery, contact microradiograph, 325.
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TABLE II. In Vitro Studies on Nacre’s Osteogenic Activity
Reference
Nacre Species and Treatment;
Cells and Culture Time Principal Results
199226 P. maxima; Nacre chips (500–750 lm*100 lm);
Human alveolar maxillary osteoblasts; 5–7
weeks
General chemical inducers not required to obtain bone
formation; Human osteoblasts proliferated and were
clearly attracted by nacre chips; Bone formation in the
presence of nacre
199237 P. maxima; Nacre chips (1 mm3);
Human alveolar maxillary osteoblasts;
4–6 weeks
Nacre induces different types of mineralisation in
human osteoblasts
199936 P. maxima; WSMa; rBMSCb; 7 days WSM activates osteogenic bone marrow cells with
enhanced alkaline phosphatase activity
200138 P. maxima; WSM; MRC-5c, rBMSC; 13 days In rBMSC, WSM promotes the cell proliferation and
ALPg activity as dexamethasone
200139 P. maxima; WSM and HPLC fraction; rat parie-
tal osteoblasts; 9 days
Nacre extract and the HPLC fraction have no effect on
the proliferation of mature osteoblasts; Nacre extract
stimulates Bcl-2 production in osteoblast
200240 P. maxima; WSM and four HPLC fractions;
MRC-5, rBMSC, rat calvaria osteoblasts; 13
days
WSM contains signal molecules that can stimulate the
osteogenic pathway in mammalian cells
200317 P. maxima; WSM; MC3T3-E1d; 6 days WSM speeds up the differentiation and mineralisation
more effectively than dexamethasone; WSM inhibits
ALP activity and that of dexamethasone
200341 P. maxima; WSM; MRC-5, rBMSC, MC3T3-E1,
MG63e; 14 days
WSM contains the signals responsible for the biological
activity of the whole nacre; WSM acts in particular on
osteoblastic cell differentiation up until mineralisation
200442 Haliotis tuberculata; WSM; MRC-5, rBMSC,
MC3T3-E1, MG63; 14 days
WSM contains signal molecules responsible for the
recruitment of mammal cells in the osteogenic path-
way and bone cell activation undergoing a complete
sequence of mineralisation
200643 P. fucata; Matrix protein p10 from nacre;
MRC-5, MC3T3-E1; 7 days
p10 increases ALP activity, while the viability of MRC-5
and MC3T3-E1 remained unchanged after treatment
of p10
200744 P. margaritifera; Slices of cylinder, 6 mm
in diameter, 800 lm slices; Human
osteoclast precursors, mouse osteoclast
precursors, rabbit mature osteoclasts; 24 h
Osteoclastic degradation of nacre is a limited process
200745 P. fucata; Protein complex p60 from nacre
(decalcification process); MC3T3-E1, rBMSC;
8 days
Von Kossa staining shows the formation of mineralised
nodules in the two cell types after the treatment of
p60 without ascorbic acid and b-glycerophosphate
200846 Nacre species unknown; WSM; Rabbit bone
marrow stromal cells; 7 days
WSM increases ALP activity, and the expression of
BMP-2, but not Runx2
200747 P. maxima; Low molecular weight molecules
(50–235 Da) of WSM; MC3T3-E1; 25 days
WSM speeds up the differentiation and mineralisation
of damaged bone tissue; Hydroxyapatite was found in
cells treated with WSM
201248 Pteria martensii; WSM and nacre powder;
Mouse calvaria osteoblast precursors, bone
marrow derived osteoclast precursors; 10
and 2 days, respectively
WSM induces osteoblast biomineralisation compared to
calcium dissolved from CaCO3. WSM suppresses
osteoclast formation; Related signaling pathways are
also revealed
201349 P. fucata; WSM; MC3T3-E1; 9 days WSM induces differentiation of the preosteoblasts in
mature osteoblasts
201550 P. maxima; WSM and nacre chips (500–750 lm
3 100 lm); Human bone marrow stromal
cells; 21 days
Nacre induces the early stages of human bone cell
differentiation
201551,52 P. margaritifera; ESMf; MC3T3-E1 and human
osteoblasts; 21 days
ESM can restore the mineralisation capacity of osteoar-
thritis osteoblasts
aWSM: water soluble matrix.
brBMSC: rat bone marrow stromal cells.
cMRC-5: human fetal lung tissue fibroblasts cell line.
dMC3T3-E1: murine calvaria pre-osteoblasts cell line.
eMG63: human osteosarcoma cell line.
fESM: ethanol soluble matrix.
gALP: alkaline phosphatase.
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in vivo studies. As nacre is osteoinductive in vivo and mani-
fests many great qualities as a bone graft substitute, it is
important to determine the internal mechanisms of action
and to identify the responsible signal molecules in the osteo-
genic process, before the routine use of nacre in clinics.
Biocompatibility, osteoinduction, osteoconduction of
nacre, and the mechanisms of its action. When nacre
chips were placed with human alveolar maxillary osteo-
blasts, without any regular chemical inducers to obtain
bone mineralization in vitro, osteoblasts proliferated and
were attracted by nacre chips. The osteoblasts surrounding
the nacre chips mineralised preferentially, suggesting that
nacre was biocompatible, osteoinductive and osteoconduc-
tive.26 As a pioneering model, the studies were
repeated,37,39,40 and developed in order to explore the
mechanisms of osteoinduction by nacre. Then the nacre
chips were placed beside bone chips on a layer of human
osteoblasts: a strong osteogenic effect of the nacre on the
osteoblasts was observed. New bone formation occurred by
growth on the existing bone and by the formation of miner-
alised nodules within the matrix adjacent to the bone
explant.37 This phenomenon confirmed the results observed
in a study in vivo.28 It’s believed that nacre contains some
signal molecules that are released when placed in living sys-
tems. Nacre could attract and activate both bone marrow
stem cells and osteoblasts.35 Related to nacre extracts,
water soluble matrix (WSM), or a fraction thereof, was
mostly tested. WSM can be extracted by water without
decalcification. It was argued that osteoblastic cells from
marrow or other bone surface-derived osteoblast stem cells
had the inherent direct potential for osteogenesis.38 Thus,
rat bone marrow stomal cells (rBMSCs),36,38,40,41 human
fibroblast cell lines from fetal lung tissue (MRC-5),38,40,41 a
model of immature osteoblasts, human osteosarcoma cell
lines (MG63),41,42 and human bone marrow stomal cells
(hBMSCs),50 were used for evaluating the osteostimulatory
effect of WSM in the early stages of cellular differentiation.
The MC3T3-E1 pre-osteoblast cell line from mouse calvaria
has also been widely used17,41,42,47,49: it can differentiate
into osteoblasts and mineralize in the presence of b-
glycerophosphate and ascorbic acid. WSM extensively
enhanced the alkaline phosphatase (ALP) activity, an early
marker of cellular osteogenic differentiation, in all cells
tested,36,38–40,42,46,49,50 but only in one study for MC3T3-
E1.17 Nacre also increased the osteocalcin levels in
rBMSCs,41 and Bcl-2 production in mature rat osteoblasts.39
For the bone differentiation markers, WSM accelerated or
increased the expression of Collagen I, Osteocalcin, Runx2,
Osteopontin genes in MC3T3-E1,46,47 ALP in hBMSC,50 and
BMP-2 but not Runx2 in rabbit BMSCs.46 WSM accelerated
the hydroxyapatite deposition in MC3T3-E1, supported by
Von Kossa and Alizarin Red stainings,17,41,46,47 confirmed by
SEM observation and Raman spectroscopy.47 Lately, it was
proven that ESM (Ethanol soluble matrix) had a similarly
osteoinductive effect in MC3T3-E1 and human osteoarthritis
osteoblasts.51,52
Identification of active nacre compounds for
osteogenesis. HPLC fractions of WSM, for example, p10 and
p60, were demonstrated to have an osteostimulatory
effect.38,39,45,49 The nacre proteins were equally proven to
play a primary role in controlling the formation of the inter-
facial structure and biocompatibility with bone as well as
the stability of biogenic tissues.53 It has been argued that
the nacre molecules efficient in bone cell differentiation are
probably more related to peptides.17,47 Much effort is pres-
ently being made to discover the active compounds respon-
sible for the osteogenic property of nacre.
Biodegradability of nacre. When human osteoclast precur-
sors from blood, mouse osteoclast precursors from spleen
and mature rabbit osteoclasts from long bones were cul-
tured with nacre slices, osteoclast precursors differentiated
into osteoclasts capable of resorbing nacre. But nacre
resorption efficiency was always lower than that of bone
and appeared to be a limited process.44 Even more, WSM
suppresses the osteoclast formation.48 Thus, the cell-
mediated absorption of nacre slices in vitro was limited.
DISCUSSION AND CONCLUSION
What might reasonably be seen as nacre’s contribution
to current orthopaedic clinics?
Having witnessed the various designs of nacre in in vivo
studies, it is easy to envisage some specific uses of nacre in
orthopaedic clinics. As blocks, pieces, chips or in the shape
of bone devices, nacre can be used (i) to offer mechanical
support at load-bearing sites, for example, at defects in
major long bones and in the jaw bone and (ii) to fill large
bone defects at no-load sites, for example, the cranial defect.
Nacre can also be used to promote an intervertebral or
interlaminar fusion when an open dissection is taken.
Finally, nacre offers a permanent fixation between fractured
bones and there is no need to remove it after an implant.
Nacre’s biocompatibility, osteoinductivity, osteoconductivity
and its excellent mechanical properties all benefit from its
large-scale availability. As no a powder, nacre can be used
as an injectable material to fit certain mini-invasive surgery
needs, particularly in spinal surgery. The injectable material
may also have a better market for filling semi-closed bone
defects caused by cyst or benign tumours than nacre pieces.
Being added into other grafting biomaterials, nacre may
improve the osteoinductivity and osteoconductivity. In addi-
tion, nacre powder may be used as a basal and machinable
biomaterial in 3D printing, to make a personalized implant
for nonload bearing bone defects.54 Nacre extracts could be
used as surface-coatings for different bone graft substitutes
to improve the osteoinductivity,55 by stimulating osteoblasts
and suppressing osteoclasts. To date, it seems that no mate-
rial is perfect for bone repair. The current strategies for
bone graft substitutes are confronted with incredible com-
plexity and difficulty, many of which could be avoided, by
using nacre, an outstanding biomaterial. This natural marine
biomaterial possesses many advantages, for example, low
cost, sophisticated predesign of hierarchical structures and
architectures for bio recognition, intrinsic biological
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functions, possibility of low-level immunogenicity, low cyto-
toxicity, and easy safe storage.56 Because of its remarkable
mechanical properties and biological effects in the bone
environment, nacre can be designed specifically to corre-
spond to each of the multiple clinical needs for bone graft
substitution or bone regeneration. Though further progress
in our understanding must still be made, we fully believe
that nacre has a revolutionary potential in the field of bone
substitutes.
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